Triodos Investment Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Hold
147,000
0.18% 47
2025
Q4
$2.64M Buy
147,000
+14,500
+11% +$254K 0.19% 48
2025
Q3
$2.45M Buy
132,500
+20,000
+18% +$412K 0.18% 48
2025
Q2
$2.42M Buy
112,500
+22,500
+25% +$486K 0.18% 48
2025
Q1
$2.23M Sell
90,000
-3,000
-3% -$74.1K 0.18% 47
2024
Q4
$2.16M Buy
93,000
+21,000
+29% +$525K 0.17% 48
2024
Q3
$1.95M Buy
72,000
+30,500
+73% +$924K 0.15% 48
2024
Q2
$1.19M Buy
41,500
+500
+1% +$15.3K 0.1% 47
2024
Q1
$1.2M Buy
41,000
+6,000
+17% +$168K 0.11% 47
2023
Q4
$1.14M Buy
35,000
+10,000
+40% +$290K 0.11% 46
2023
Q3
$800K Buy
25,000
+5,000
+25% +$193K 0.09% 47
2023
Q2
$877K Sell
20,000
-1,000
-5% -$46.1K 0.09% 45
2023
Q1
$930K Buy
21,000
+2,000
+11% +$88.4K 0.1% 45
2022
Q4
$755K Buy
19,000
+4,000
+27% +$167K 0.1% 42
2022
Q3
$692K Hold
15,000
0.1% 43
2022
Q2
$647K Buy
+15,000
New +$686K 0.09% 45

Other funds holding KIDS

Triodos Investment Management's KIDS Position: Q1 2026 in Review

Triodos Investment Management held its OrthoPediatrics (KIDS) position steady in Q1 2026 at 147,000 shares worth $2.33M. The position accounts for 0.18% of the portfolio, ranked #47.

Triodos Investment Management first reported a position in KIDS in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.64M in Q4 2025. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Triodos Investment Management held 147,000 shares of OrthoPediatrics worth $2.33M as of Q1 2026.
  • Triodos Investment Management left its OrthoPediatrics share count unchanged in Q1 2026.
  • OrthoPediatrics made up 0.18% of Triodos Investment Management's portfolio in Q1 2026, its #47 holding.
  • Triodos Investment Management first reported a position in OrthoPediatrics in Q2 2022 and has held it in 16 quarters since.
  • Triodos Investment Management's OrthoPediatrics position peaked at $2.64M in Q4 2025.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Triodos Investment Management's 13F filing for Q1 2026, filed 7 May 2026.